Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

GONAL-F

EMD SERONO, A DIVISION OF EMD INC., CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is GONAL-F discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that GONAL-F 5.5MCG has been permanently discontinued (last updated September 3, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is GONAL-F not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file2 products
Affected strength5.5MCG
Last updated2025-09-03

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

GONAL-F

EMD SERONO, A DIVISION OF EMD INC., CANADA

75UNIT · DIN 02231464

Different strengthSame dosage formSame routeNo current shortage

GONAL-F PEN

EMD SERONO, A DIVISION OF EMD INC., CANADA

900UNIT · DIN 02270382

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02248154

Strength

5.5MCG

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAMUSCULAR

Active Ingredient

FOLLITROPIN ALFA

See all FOLLITROPIN ALFA products →

Shortage History